Ayer Capital Management

Latest statistics and disclosures from Ayer Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are Lion Biotechnologies, Oncothyreon, and represent 100.00% of Ayer Capital Management's stock portfolio.
  • Reduced shares in these 1 stock: Lion Biotechnologies (-$26M).
  • Ayer Capital Management was a net seller of stock by $-26M.
  • Ayer Capital Management has $27M in assets under management (AUM), dropping by -60.71%.
  • Central Index Key (CIK): 0001471149

Portfolio Holdings for Ayer Capital Management

Ayer Capital Management holds 2 positions in its portfolio as reported in the June 2015 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Lion Biotechnologies 96.5 $26M -49% 2.8M 9.17
 View chart
Oncothyreon 3.5 $935k 250k 3.74
 View chart

Past Filings by Ayer Capital Management

SEC 13F filings are viewable for Ayer Capital Management going back to 2010